The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA Trial(, )

We present the rationale for and design of a randomized, open-label, active-control trial comparing the effectiveness of 200 units of onabotulinum toxin A (Botox A®) versus sacral neuromodulation (InterStim®) therapy for refractory urgency urinary incontinence (UUI). The Refractory Overactive Bladde...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Amundsen, Cindy L., Richter, Holly E., Menefee, Shawn, Vasavada, Sandip, Rahn, David D., Kenton, Kim, Harvie, Heidi S., Wallace, Dennis, Meikle, Susie
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3989885/
https://ncbi.nlm.nih.gov/pubmed/24486637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2014.01.009
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky